Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease

被引：0
|
作者：
Georgantas, Robert W. [1 ]
Bohana-Kashtan, Osnat [1 ]
Civin, Curt I. [1 ,2 ]
机构：
[1] Johns Hopkins, Div Immunol & Hematopoiesis, Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.1137
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1041
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [21] Decidual stromal cells as treatment for acute graft versus host disease
    Solders, M.
    Remberger, M.
    Erkers, T.
    Nava, S.
    Mollden, P.
    Mattsson, J.
    Kaipe, H.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S24 - S24
  • [22] Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
    Solders, Martin
    Erkers, Tom
    Remberger, Mats
    Nava, Silvia
    Mollden, Pia
    Mattsson, Jonas
    Kaipe, Helen
    Ringden, Olle
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S349 - S350
  • [23] Sitagliptin to reduce acute graft-versus-host disease
    Heinitz, Sascha
    DIABETOLOGE, 2021, 17 (03): : 338 - 339
  • [24] Ex vivo lymphocyte TLR7 tolerance induction effectively prevents murine acute graft-versus-host disease
    Zogas, N.
    Karponi, G.
    Paraskevas, V.
    Iordanidis, F.
    Scouras, Z.
    Anagnostopoulos, A.
    Yannaki, E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S375 - S376
  • [25] Depletion of Naive Lymphocytes with Fas Ligand Ex Vivo Prevents Graft-versus-Host Disease without Impairing T Cell Support of Engraftment or Graft-versus-Tumor Activity
    Askenasy, Nadir
    Mizrahi, Keren
    Ash, Shifra
    Askenasy, Enosh M.
    Yaniv, Isaac
    Stein, Jerry
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 185 - 195
  • [26] Murine mesenchymal stem cells fail to suppress acute graft versus host disease
    Peranteau, WH
    Badillo, AT
    Alcorn, K
    Filice, S
    Flake, AW
    BLOOD, 2005, 106 (11) : 397B - 397B
  • [27] Prevention of murine acute graft-versus-host disease by staphylococcalenterotoxin B treatment
    Takenaka, K
    Fujiyama, Y
    Andoh, A
    Sasaki, T
    Amakata, Y
    Matsubara, H
    Hodohara, K
    Bamba, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (01): : 155 - 161
  • [28] Treatment of steroid and extracorporeal resistant acute Graft-versus-Host Disease with donor mesenchymal stem cells
    da Silva, Claudia Lobato
    dos Santos, Francisco
    Andrade, Pedro Z.
    Miranda, Nuno
    Teixeira, Gilda
    Guimaraes, Antonio
    Ferreira, Isabelina
    Rodriguez, Ernesto
    Oliveira, Josefina
    Trindade, Helder
    Cabral, Joaquim M. S.
    Abecasis, Manuel
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S34 - S34
  • [29] Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease
    Arbez, Jessy
    Saas, Philippe
    Lamarthee, Baptiste
    Malard, Florent
    Couturier, Melanie
    Mohty, Mohamad
    Gaugler, Beatrice
    CYTOTHERAPY, 2015, 17 (07) : 948 - 955
  • [30] Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease
    Dittmar, David J.
    Pielmeier, Franziska
    Strieder, Nicholas
    Fischer, Alexander
    Herbst, Michael
    Stanewsky, Hanna
    Wenzl, Niklas
    Roeseler, Eveline
    Eder, Ruediger
    Gebhard, Claudia
    Schwarzfischer-Pfeilschifter, Lucia
    Albrecht, Christin
    Herr, Wolfgang
    Edinger, Matthias
    Hoffmann, Petra
    Rehli, Michael
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345